Lv2
148 积分 2025-07-24 加入
An ultrasensitive FEN1-aided LCR-electrochemical biosensor enables detection of BCR/ABL1 fusion transcripts in clinical samples for early diagnosis and minimal residual monitoring of CML
1天前
已关闭
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
4天前
已完结
Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan
4天前
已完结
MDS-278 Mixed-Methods Study Assessing the Impact of C3 Inhibition on the Emotional and Physical Burden of Living With Paroxysmal Nocturnal Hemoglobinuria
25天前
已关闭
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
1个月前
已完结
Prognostic value of thymidine kinase activity in patients with chronic lymphocytic leukemia
1个月前
已关闭
Breakthrough Hemolysis in PNH with Proximal or Terminal Complement Inhibition
1个月前
已完结
Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Diagnosis and Treatment of Chronic Lymphocytic Leukemia
1个月前
已完结
The efficacy and survival impact of chidamide on angioimmunoblastic T‐cell lymphoma based on Epstein‐Barr virus stratification in the real world: A multicenter study
2个月前
已完结
皖公网安备34019202002308
